Abstract:BACKGROUND The study aim was to present details of the perioperative and long-term outcomes of redo-endoscopic port access surgery (REPAS) for late atrioventricular valve disease (AVVD) in orthotopic cardiac transplant (OCT) patients. METHODS Between February 2004 and October 2015, REPAS was performed for late AVVD in seven consecutive OCT patients (mean age 57.9 ± 17.2 years; EuroSCORE II 21.2 ± 14.7%) at the authors' institution. The mean OCT-REPAS time interval was 7.8 ± 4.6 years (range: 1.3-13.8 years). NYHA class III or IV symptoms were present in four patients (57%). The mean left ventricular ejection fraction was 52.9 ± 3.9%, and surgical indications included severe mitral valve (MV) and tricuspid valve (TV) regurgitation in three patients (44%) and six patients (86%), respectively. Etiological factors included endomyocardial biopsy trauma (n = 6; 86%), degenerative disease (n = 2; 29%), and fungal endocarditis (n = 1; 14%). RESULTS Procedures performed included MV repair (n = 3; 43%) and TV replacement (n = 3; 43%). There were no sternotomy conversions or revisions for any cause. The mean cardiopulmonary bypass and ischemic times were 178.4 ± 48.6 min and 118.3 ± 39.5 min, respectively. In-hospital morbidities included hospital-acquired pneumonia (n = 2; 29%). There were no wound infections or 30-day mortalities. The mean duration of hospitalization was 18.3 ± 11.0 days. A mean of 29.2 ± 45.6 patient-months (total 204.3 patient-months) was available for long-term clinical and echocardiographic analysis (n = 7; 100% complete). No MV or TV reinterventions were required. NYHA class ≤II was achieved in five patients (71%). No patient presented with residual MV regurgitation greater than grade I. CONCLUSIONS REPAS for late AVVD in OCT patients is a safe and durable procedure with favorable technique-related mortality, in-hospital morbidity, and long-term cardiac-specific outcomes at experienced centers. The present technique provided an attractive benchmark against which emerging percutaneous interventions may be measured, and earlier referral of patients should be considered.

Smectic mesophases of functionalized silver and gold nanoparticles with anisotropic plasmonic properties.

Orbital Apex Syndrome Caused by Ethmoid Sinus Mucocele: A Case Report and Review of Literature

Cholesterol granuloma of the maxillary sinus: a case report

Optic Neuritis Related to Chronic Sphenoid Sinusitis as an Uncommon Cause of Vision Loss: A Case Report and Literature Review

Optic nerve compression in allergic fungal sinusitis

[Rhinogenic neuropathia of the optic nerve due to muco- and pyoceles of the sphenoid sinus and posterior ethmoid cells]

Chronic chiasmal compression and persistent visual field defect without detectable changes in optical coherence tomography of the macular ganglion cell complex

Onodi Cell Mucocele with Cholesterol Granuloma is More Likely to Cause Serious Optic Neuropathy, Compared with Simple Onodi Cell Mucocele

Clinicopathological Features and Management of Orbital Cholesterol Granuloma

Intra-optic nerve abscess: A rare complication of acute sinusitis

Sphenoethmoidal air cell sinusitis: A rare cause of recurrent optic neuritis

Endoscopic Port Access Surgery for Late Orthotopic Cardiac Transplantation Atrioventricular Valve Disease.

RELATIONSHIP OF OPTIC NEURITIS TO DISEASE OF THE PARANASAL SINUSES

Optic Neuritis Secondary to Paranasal Sinusitis: A Case Report

Idiopathic Hypertrophic Cranial Pachymeningitis with Scleritis and Optic Disc Involvement: a Case Report and Literature Review.

Experimental setup for studying the effects of alpha particles on zebrafish embryos

Optic nerve changes in chronic sinusitis patients: Correlation with disease severity and relevant sinus location

Protrusion of the optic nerve into the ethmoid and sphenoid sinus: prospective study of 150 CT studies